Adapthealth Corp

Company Profile

Adapthealth Corp had its IPO on 2018-05-24 under the ticker symbol AHCO.

The company operates in the Healthcare sector and Medical Devices industry. Adapthealth Corp has a staff strength of 10,900 employees.

Stock update

Shares of Adapthealth Corp opened at $10.64 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $10.59 - $10.91, and closed at $10.61.

This is a -0.75% slip from the previous day's closing price.

A total volume of 725,795 shares were traded at the close of the day’s session.

In the last one week, shares of Adapthealth Corp have slipped by -10.01%.

Adapthealth Corp's Key Ratios

Adapthealth Corp has a market cap of $2.03 billion, indicating a price to book ratio of 1.2577 and a price to sales ratio of 0.9329.

In the last 12-months Adapthealth Corp’s revenue was $2.97 billion with a gross profit of $471.63 million and an EBITDA of $567.29 million. The EBITDA ratio measures Adapthealth Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Adapthealth Corp’s operating margin was 7.28% while its return on assets stood at 2.58% with a return of equity of 3.46%.

In Q4, Adapthealth Corp’s quarterly earnings growth was a negative -45.3% while revenue growth was a positive 9.5%.

Adapthealth Corp’s PE and PEG Ratio

Forward PE

16.835

Trailing PE

45.4242

PEG

Its diluted EPS in the last 12-months stands at $0.33 per share while it has a forward price to earnings multiple of 16.835 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Adapthealth Corp’s profitability.

Adapthealth Corp stock is trading at a EV to sales ratio of 1.7548 and a EV to EBITDA ratio of 8.8154. Its price to sales ratio in the trailing 12-months stood at 0.9329.

Adapthealth Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$5.22 billion

Total Liabilities

$456.21 million

Operating Cash Flow

$0

Capital Expenditure

$142.91 million

Dividend Payout Ratio

0%

Adapthealth Corp ended 2024 with $5.22 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $5.22 billion while shareholder equity stood at $2.16 billion.

Adapthealth Corp ended 2024 with $0 in deferred long-term liabilities, $456.21 million in other current liabilities, in common stock, $26.30 million in retained earnings and $3.55 billion in goodwill. Its cash balance stood at $46.27 million and cash and short-term investments were $46.27 million. The company’s total short-term debt was $67,212,000 while long-term debt stood at $2.15 billion.

Adapthealth Corp’s total current assets stands at $585.31 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $359.15 million compared to accounts payable of $337.50 million and inventory worth $127.75 million.

In 2024, Adapthealth Corp's operating cash flow was $0 while its capital expenditure stood at $142.91 million.

Comparatively, Adapthealth Corp paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$10.61

52-Week High

$27.48

52-Week Low

$11.4

Analyst Target Price

$23.44

Adapthealth Corp stock is currently trading at $10.61 per share. It touched a 52-week high of $27.48 and a 52-week low of $27.48. Analysts tracking the stock have a 12-month average target price of $23.44.

Its 50-day moving average was $12.72 and 200-day moving average was $15.03 The short ratio stood at 13.89 indicating a short percent outstanding of 0%.

Around 2338.5% of the company’s stock are held by insiders while 8457.8% are held by institutions.